James Fry

Mark's practice covers cross border inward investment, syndicated lending, structured export credit finance, structured trade and commodity finance, debt restructurings and asset finance. Mark is recognized in The Legal 500 UK as "excelling" in structured export credit transactions and is praised for his "commercial and user-friendly approach."Mark advises on ESG financings including hospitals, clean energy and transportation.Mark also advises on financial crime, modern slavery, bribery and c...

Eleanor West advises clients on UK and international private equity investments and buyout transactions, acting for institutions and management teams. Eleanor also advises corporate clients on cross-border merger and acquisition, joint venture and restructuring matters.

Charlie Caher is a partner in the Firm's Litigation/Controversy Department, and a member of the International Arbitration Practice Group. He joined the Firm in 2008. Mr. Caher is based in the London office, where he practices International Arbitration and English High Court Litigation.

Ingrid Gubbay is a top attorney recognized by Best Lawyers in the practice area(s) of Environmental Law. Ingrid, who practices law in London, United Kingdom, has been recognized since 2024. This recognition is based on an exhaustive peer-review survey, reflecting the high esteem in which Ingrid is held by other top lawyers in the same geographic and legal practice area.

Malcolm Bates is a partner in Goodwin’s Technology and Life Sciences groups based in Cambridge and London. He specialises in the commercialisation of intellectual property rights with particular expertise in life sciences. Mr. Bates advises on transactions, including licences, collaborations, distribution, manufacturing, outsourcing and R&D projects, as well as regulatory matters, contract and patent disputes, fundraisings, M&A transactions and IPOsPrior to joining Goodwin, he w...

Prior to joining Skadden, Mr. Gal led the strategic development of the Middle Eastern litigation practice of another major U.S. law firm. Over the course of the last 20 years, he has represented some of the world’s leading companies in sectors such as telecommunications, banking and finance, infrastructure, energy, construction and technology under a variety of different rules including ICC, ICSID, LCIA, UNCITRAL, AAA and ad hoc arbitrations. He served, until recently, as one of Austral...

Tim is a partner in Goodwin’s Technology and Life Sciences groups, based in the Cambridge and London offices.Mr. Worden regularly advises life sciences companies on licensing and partnering deals, R&D agreements, clinical trials agreements, distribution agreements, and a broad spectrum of regulatory matters. His expertise also includes advising on the IP and regulatory aspects of M&A transactions, IPOs and venture capital investments. Outside of the life sciences sector, Mr. Wor...

Tony Horspool is a top attorney recognized by Best Lawyers in the practice area(s) of Insolvency and Restructuring Law. Tony, who practices law in London, United Kingdom, has been recognized since 2014. This recognition is based on an exhaustive peer-review survey, reflecting the high esteem in which Tony is held by other top lawyers in the same geographic and legal practice area.

James Fisher is a partner in the Finance Group in Alston & Bird’s London office, focusing on debt capital markets, structured finance, securitisation, and derivatives transactions, with a particular specialty in advising corporate trust, agency, and issuer clients across a broad spectrum of cross-border and domestic financings.

Bill Schnoor is a partner in and former co-chair of the firm’s Technology and Life Sciences groups. He works in all areas of corporate, securities and partnership laws, with a primary focus on advising high-growth technology and life sciences companies. He joined Goodwin in 2005, after a 21-year career with Testa, Hurwitz & Thibeault, LLP, and quickly became co-chair of Goodwin’s technology and life sciences practices. Under his leadership the Technology and Life Sciences grou...